Jane Street’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
167,493
+75,277
| +82% | +$705K | ﹤0.01% | 2377 |
|
|
2025
Q1 | $1.13M | Buy |
92,216
+79,468
| +623% | +$976K | ﹤0.01% | 2904 |
|
|
2024
Q4 | $169K | Sell |
12,748
-120,793
| -90% | -$1.6M | ﹤0.01% | 5170 |
|
|
2024
Q3 | $2.57M | Sell |
133,541
-19,770
| -13% | -$381K | ﹤0.01% | 2072 |
|
|
2024
Q2 | $3.15M | Buy |
153,311
+39,783
| +35% | +$817K | ﹤0.01% | 2209 |
|
|
2024
Q1 | $2.7M | Buy |
113,528
+6,462
| +6% | +$154K | ﹤0.01% | 1932 |
|
|
2023
Q4 | $2.31M | Sell |
107,066
-43,065
| -29% | -$931K | ﹤0.01% | 2334 |
|
|
2023
Q3 | $2.18M | Buy |
150,131
+108,546
| +261% | +$1.58M | ﹤0.01% | 2140 |
|
|
2023
Q2 | $870K | Sell |
41,585
-21,802
| -34% | -$456K | ﹤0.01% | 3204 |
|
|
2023
Q1 | $1.34M | Buy |
63,387
+44,727
| +240% | +$945K | ﹤0.01% | 2476 |
|
|
2022
Q4 | $475K | Buy |
+18,660
| New | +$475K | ﹤0.01% | 3458 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6307 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6219 |
|
|
2022
Q1 | – | Sell |
-21,778
| Closed | -$477K | – | 6159 |
|
|
2021
Q4 | $477K | Buy |
+21,778
| New | +$477K | ﹤0.01% | 3523 |
|
|
2021
Q2 | – | Sell |
-19,033
| Closed | -$425K | – | 5713 |
|
|
2021
Q1 | $425K | Sell |
19,033
-33,813
| -64% | -$755K | ﹤0.01% | 3523 |
|
|
2020
Q4 | $1.18M | Buy |
+52,846
| New | +$1.18M | ﹤0.01% | 1948 |
|
|
2020
Q3 | – | Sell |
-36,575
| Closed | -$541K | – | 4380 |
|
|
2020
Q2 | $541K | Buy |
+36,575
| New | +$541K | ﹤0.01% | 2471 |
|